The Impact of LRRK2 G2019S on Parkinson's Disease: Clinical Phenotype and Treatment in Tunisian Patients.
Guedi Ali BarrehIkram SghaierYoussef AbidaAlya GharbiAmina NasriSaloua MrabetAmira SouissiMouna Ben DjebaraSameh TrabelsiImen KacemAmina Gargouri-BerrechidRiadh GouiderPublished in: Journal of movement disorders (2024)
The present study demonstrated that the variability of the clinical profile among Tunisian PD patients was explained by the incomplete penetrance of LRRK2-G2019S, which increased with age. Further studies using biomarker and disease progression data are necessary to improve PD management.